Compound Detail

CHEMBL4783901

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

O=C(Nc1ccc([N+](=O)[O-])cc1)C(c1ccccc1)N(C(=O)C(Cl)(Cl)Cl)c1ccccc1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL4783901
Phase	Preclinical
Structure Type	MOL
InChI Key	ZQOSSHIUYBTWFP-UHFFFAOYSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

492.8

MW (Da)

5.68

ALogP

HBA

HBD

92.5

PSA (Å²)

0.27

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 4 meas. best 7.96

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
MCF7 CHEMBL387	IC50	7.96	7.96	11.0	1
Unchecked CHEMBL612545	IC50	7.64	7.64	22.8	1
HepG2 CHEMBL395	IC50	7.51	7.51	30.9	1
WI-38 CHEMBL614391	IC50	5.34	5.34	4564.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
MCF7	IC50	=	11.0	nM	7.96	Anticancer activity against human MCF7 cells assessed as reduction in cell viabi...	31740054
Unchecked	IC50	=	22.8	nM	7.64	Anticancer activity against human NFS-60 cells assessed as reduction in cell via...	31740054
HepG2	IC50	=	30.9	nM	7.51	Anticancer activity against human HepG2 cells assessed as reduction in cell viab...	31740054
WI-38	IC50	=	4564.0	nM	5.34	Cytotoxicity against human WI-38 cells assessed as reduction in cell viability b...	31740054

PubMed	DOI	Target Context	# Activities
31740054	10.1016/j.ejmech.2019.111875	Unchecked	4
31740054	10.1016/j.ejmech.2019.111875	WI-38	2
31740054	10.1016/j.ejmech.2019.111875	MCF7	1
31740054	10.1016/j.ejmech.2019.111875	HepG2	1

Data from ChEMBL 36 via Core Engine